The vaccines division of Sanofi, Sanofi Pasteur, announced the launch of ShanIPV, an injectable Inactivated Polio Vaccine (IPV).
According to reports, Telangana Chief Minister K Chandrasekhar Rao launched the vaccine. Shantha Biotechnics , Sanofi Pasteur's affiliate in Hyderabad would be responsible for the manufacturing of ShanIPV. ShanIPV is a trivalent inactivated, injectable polio vaccine. 
Sanofi Pasteur and Shantha would provide majority of vaccine doses needed for the introduction by the end of 2016. All vaccines (both Imovax Polio of Sanofi Pasteur and ShanIPV of Shantha) would be delivered in India through UNICEF.
Shailesh Ayyangar, Managing Director - India and Vice President - South Asia, Sanofi said that with the introduction of IPV in the immunization schedule, the Company is playing a key role in achieving the goal of a polio-free world.
Mahesh Bhalgat, Executive Director and Chief Operating Officer, Shantha Biotechnics told media that manufacturing of IPV will be a step towards the Polio Eradication Programme. He further said that Shantha Biotechnics will manufacture massive quantities of high-quality, safe and efficacious IPV vaccines to meet all the milestones in the timeline set by the Indian Government.
India was declared a polio-free nation in 2014.
"In line with the WHO's Global endgame strategy, India is introducing one dose of IPV at 14 weeks of age. IPV is to be given in addition to the existing oral polio vaccine. This introduction is a critical step towards achieving a polio-free world by 2019 to meet the Global Polio Eradication Initiative Endgame Strategic Plan," the company said.
View Latest News:
- Biotechnology Students Develop Substitute For Chemical Antibiotics ! Win Bronze Medal !
- Roche Drops Plan of Continuing the High-Profile $485.3 Million Superbug Antibiotic Project
- Dementia is Responsible for Depletion of DNA Repair Protein BRCA1 which can cause Cognitive Deficits
- Researchers Discover Specific Protein Group that Triggers Changes in Cancer Stem Cell Generation